Lessons Learned From the Introduction of Inactivated Poliovirus Vaccine in Bangladesh

J Infect Dis. 2017 Jul 1;216(suppl_1):S122-S129. doi: 10.1093/infdis/jiw510.

Abstract

Background: We assessed programmatic adaptations and infants' uptake of inactivated poliovirus vaccine (IPV) after its introduction into the routine immunization schedule in Bangladesh.

Methods: Using convenience and probability sampling, we selected 23 health facilities, 36 vaccinators, and 336 caregivers, within 5 districts and 3 city corporations. We collected data during August-October 2015 by conducting interviews, reviewing vaccination records, and observing activities.

Results: Knowledge about IPV was high among vaccinators (94%). No problems with IPV storage, transport, or waste disposal were detected, but shortages were reported in 20 health facilities (87%). Wastage per 5-dose vaccine vial was above the recommended 30% in 20 health facilities (87%); all were related to providing <5 doses per open vial. Among eligible infants, 87% and 86% received the third dose of pentavalent and oral poliovirus vaccine, respectively, but only 65% received IPV at the same visit. Among 73 infants not vaccinated with IPV, 58% of caregivers reported that vaccine was unavailable.

Conclusions: Bangladesh successfully introduced IPV, but shortages related to insufficient global supply and high vaccine wastage in small outreach immunization sessions might reduce its impact on population immunity. Minimizing wastage and use of a 2-dose fractional-IPV schedule could extend IPV immunization to more children.

Keywords: inactivated poliovirus vaccine; new vaccine introduction; polio; routine immunization.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Bangladesh / epidemiology
  • Health Knowledge, Attitudes, Practice
  • Health Personnel / statistics & numerical data*
  • Humans
  • Immunization Programs / statistics & numerical data*
  • Immunization Programs / supply & distribution*
  • Immunization Schedule
  • Infant
  • Poliomyelitis / prevention & control*
  • Poliovirus Vaccine, Inactivated / administration & dosage*

Substances

  • Poliovirus Vaccine, Inactivated